Insulin glargine is cost-effective in treatment of patients with diabetes type-2 in whom nph insulin does not provide adequate glycaemic control – The case of poland

Saved in:
Bibliographic Details
Published in:Value in health 2013-05, Vol.16 (3), p.A165-A165
Main Authors: Szmurlo, D, Kostrzewska, K, Fundament, T, Kopec, G, Wojtarowicz, M, Drzal, R, Stawujak, G, Labak-Klimasara, M, Glasek, M, Lis, J, Plisko, R
Format: Article
Language:English
Subjects:
Internal Medicine
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1098-3015
DOI:10.1016/j.jval.2013.03.824